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study question: Is bilateral tubotubal anastomosis a successful treatment in an outpatient patient population?
summary answer: For women wanting children after tubal sterilization, bilateral tubotubal anastomosis is an effective outpatient
treatment.
what is known already: With the current emphasis in reproductive medicine on high technology procedures, the effectiveness of
female surgical sterilization reversal is often overlooked. Previous clinical studies of tubal sterilization reversal have been mostly retrospective
analyses of small patient populations.
studydesign, size, duration: Acohort ofwomenwhounderwent outpatient bilateral tubotubal anastomosis from January 2000 to
June 2013 was followed prospectively until December 2014 to determine the proportions of women undergoing the procedure who became
pregnant and who had live births. Data were collected at the time of pregnancy. Differences in pregnancy rates and live birth rates associated
with age, race and sterilization method were evaluated.
participants/materials, setting, methods: A total of 6692 women, aged 20–51 years, underwent outpatient bilateral
tubotubal anastomosis.
main results and the role of chance: The crudeoverall pregnancy ratewas 69%.The crudeoverall birth ratewas35%.Results
varied according to age at sterilization reversal and themethod of sterilization.Women under 30 years of age at reversal of ring/clip sterilizations
had an88%pregnancy rateand62%birth rate. Pregnancyandbirth rates declined as age increasedat sterilization reversal.Coagulation sterilization
reversals resulted in the lowest rates of pregnancies and births. Ligation/resection reversals had intermediate success rates.
limitations, reasons for caution: Limitations of our study include probable underreporting of pregnancies based on patient-
initiated reports; possible errors in the reporting of pregnancies or early miscarriages that may have been based solely on home pregnancy tests;
and probable over-reporting of the diagnosis of ectopic pregnancies. We identified age and sterilization method as being associated with subse-
quent pregnancy, however, in order to be consideredpredictive, the associationswould need to be validated in an independent second prospect-
ively studied group of representative patients. Finally, we also included patients in the study population who had additional surgical procedures
performed at the time of tubotubal anastomosis (e.g. uterine myomectomy, fimbrioplasty, ovarian cystectomy and adhesiolysis), factors that
could result in differences in pregnancy statistics in our study versus other patient populations.
wider implications of the findings: The results of this study can help inform patients and clinicians about this low technology
alternative to IVF.
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Key words: bilateral tubotubal anastomosis / outpatient / female surgical sterilization / sterilization reversal / pregnancy
& The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
Human Reproduction, Vol.31, No.5 pp. 1120–1125, 2016
Advanced Access publication on March 14, 2016 doi:10.1093/humrep/dew038
Introduction
As divorce and remarriage have become more common in recent
decades, increasing numbers of women want to have children after a
tubal sterilization. During this time, reproductive endocrinology and in-
fertility specialists have largely dismissed sterilization reversal surgery in
favor of assisted reproductive technology. This change in practice oc-
curred without a supporting evidence base. The predilection for highly
technological treatments thatoutrun evidenceof superiority, accompan-
ied by the phasing out of useful lower technology treatments,may not be
in the best interest of patients. With this as the background, we studied
the effectiveness of bilateral tubotubal anastomosis for restoring fertility
after tubal sterilization in a large patient population.
This report answers three questions patients ask most often about
sterilization reversal surgery:
How likely am I tobecomepregnant?; If I becomepregnant,what is the
risk of having an ectopic pregnancy or miscarriage? and Overall, what is
my chance of having a baby?
Methods
Study design
This is the initial report from a prospective observational study of 9669
women who had tubal reparative surgeries. The surgeries were performed
in an outpatient surgical center in Chapel Hill, NC, USA, from January
2000 to June 2013.
Study participants
Among all women in the tubal surgery database, 6692 underwent bilateral
tubotubal anastomosis in an effort to conceive after tubal sterilization with
follow-up data recorded. These women comprise the study population for
this analysis.
Surgical method
Tubotubal anastomosis was defined as the joining of any two tubal segments
including: interstitial, isthmic, ampullary, infundibular or fimbrial segments.
Surgery was performed adhering to microsurgical principles through mini-
laparotomy incisions with 4× loupe magnification. Pre-emptive analgesia
and local anesthesia supplemented general anesthesia. Mean operating
time was 59 min with a standard deviation (SD) of 12.0 min.
Before surgery, acetaminophen 975 mg and ibuprofen 800 mgwere admi-
nistered bymouth for preventive analgesia. Other preoperativemedications
included oral promethazine 12.5 mg for nausea control and clonidine
0.05 mg for mild sedation.
Local anesthetic solution consisting of 0.25% bupivacaine with 1:200 000
epinephrine was injected into the skin prior to making a transverse suprapu-
bic incision. Subcutaneous tissue and fat were incised with monopolar elec-
trodissection. Local aesthetic solution was injected into the rectus fascia that
was also incised electrosurgically. The fascia was dissected from the under-
lying rectus abdominis and pyramidalis muscles that were separated in the
midline. The peritoneum was picked up and entered with sharp dissection.
Finger retraction was used to exposure the pelvic organs.
The tubal segmentswereelevatedwith finger compression as transections
were performed across adjacent tubal edges with Iris scissors. When signifi-
cant discrepancies were present between the tubal segments, the narrower
segment was incised along its antimesenteric border to reduce the diameter
differences at the anastomosis sites.
The tubal lumen was splinted with #1 monofilament polypropylene,
passing the stent proximally into the endometrial cavity and distally
through the fimbrial end. This technique ensured patency from the uterine
cavity throughout the length of the tube; it also stabilized the tube during
the anastomosis. A retention suture was placed in the mesosalpinx with
3-0 absorbable monofilament glyconate. End-to-end tubotubal anastomosis
was performed incorporating the muscularis and serosa in a single layer with
interrupted sutures of 6-0 non-absorbable monofilament polypropylene/
polyethylene. Care was taken to avoid the endothelial layer. The stent was
withdrawn from the fimbrial end of the tube. Throughout the operation,
the tubal segments and other pelvic organs were irrigated with warm hepar-
inized Lactated Ringer’s solution and microsurgical electrocautery was used
for meticulous hemostasis. After ensuring the irrigating solution was com-
pletely clear of any hemosiderin pigment, the rectus muscles were approxi-
mated in the midline with interrupted 3-0 absorbable glycolide sutures.
These sites were infiltrated with local anesthetic solution. The rectus fascia
was approximated with #0 polydioxanone interrupted sutures. These
suture sites were also infiltrated with local anesthetic solution. Camper’s
fascia and Scarpa’s fascia were approximated with 3-0 glycolide interrupted
sutures. A running suture of non-pigmented 4-0 glycolide was used to close
the reticular layer of the skin.
Data collection and analysis
Wereviewedpatients’ sterilization operative reports before reversal surgery
to determine sterilization method. At 1 year after surgery, nurses initiated
email and telephone inquiries using standardized forms to record pregnancy
information. Up to three email inquiries and two telephone calls were made
to each patient in efforts to obtain information about pregnancy status.
Additional information about pregnancies after surgery came from patient-
initiated reports submitted throughwebsite forms, email, postal mail or tele-
phone at any time throughout the duration of the study. Nurses recorded all
data contemporaneously in an electronic database.
We used survival analytic methods to assess associations between time
until first pregnancy and time until first live birth with sterilization method
and age at time of sterilization reversal. For each patient, we defined time 0
as the date of surgery. For those who became pregnant, we estimated the
date of conception as follows: for women who reported a last menstrual
period date (LMP), we used LMP + 14 days; for women without an LMP
but who reported any positive pregnancy tests, we used the date of the
first positive test; for women without reported LMP and without positive
pregnancy tests, we used the date of birth minus 38 weeks; for all other
women, we used the midpoint between the date of surgery and the date
that follow-up data were obtained. For women who experienced a live
birth, we used the baby’s date of birth when available; otherwise, we used
the estimated date of conception plus 38 weeks. As described above,
active follow-up ended 1 year post-surgery with voluntary reporting there-
after.Thus, tomitigate thepotential for informativecensoring,we tookacon-
servative approach; for women who never reported experiencing the event
of interest (pregnancyor live birth) andwhose last contact waswithin 3 years
post-surgery, we assumed that they did not experience the event during the
3 years. Therefore, estimated cumulative event probabilities should be
interpreted as approximate lower bounds. We compared time with first
pregnancy or first live birth across patient characteristics (age at surgery
and sterilization method) separately using log-rank tests. We used Kaplan–
Meier estimators to estimate the cumulative incidences of pregnancy or live
birth during the 3 years post-surgery. Analyses were conducted using SAS,
version 9.3 (SAS Institute, Cary, NC, USA). A value of P, 0.05 was consid-
ered significant.
The University of North Carolina at Chapel Hill IRB and Office of Human
Research Ethics gave this study exempt status (IRB Number 14-1783) as a
quality improvement study, meaning that written consent was not required.
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Results
The study population
The ages of the 6692 women at the time of tubotubal anastomosis
ranged from 20 to 51 years. The mean age was 34.6 years with a SD of
4.5. The age distribution was: less than 30 years (13%), 30–34 years
(37%), 35–39 years (36%) and 40 years or older (14%). The distribution
by race/ethnicitywas:white (77%), black (12%),Hispanic (7%)andother
or not stated (4%). The most common method of previous sterilization
was tubal ligation/resection (40%). Mechanical methods (tubal rings or
clips) accounted for 25% of the population and coagulation methods
for 26%. Nine percent of the women had undergone other sterilization
techniques. These included hysteroscopic tubal occlusive sterilizations,
combinations of sterilization methods or unknown procedures.
Pregnancy incidence
In total, 4633 (69%) women reportedly became pregnant during follow-
up (Table I). Pregnancy percentages ranged from 82% for women ,30
years of age to 38% for women age 40 or older at the time of tubal
repair (P, 0.001).
Pregnancy percentages were highest for women after reversal of
ring/clip sterilizations (76%), followed in descending order by thosewith
ligation/resection (68%) andcoagulation (67%)procedures (P, 0.001).
The overall cumulative incidence of pregnancy at 6 months was 41%,
95% confidence interval [40%, 42%] and at 12 months was 58% [57%,
59%]. Estimated cumulative incidences over 3 years, by age at steriliza-
tion reversal and by sterilization method, are shown in Fig. 1.
We further investigated the pregnancy incidence in subpopulations
defined jointly by age group and sterilization method (Table II).
Women younger than 35 years of age who had ring/clip procedures
experienced the highest 12-month cumulative incidence of pregnancy
(73–77%),while forwomen aged 40 years orolder the 12-month cumu-
lative incidence was lower than 50% regardless of sterilization method.
Pregnancy outcomes
The 6692 women in this study reported a total of 7275 pregnancies.
Over one-third (37%) of women who ever became pregnant during
follow-up reported more than one pregnancy. The rangewas 1–9 preg-
nancies, with a mean of 1.5 and SD of 0.9. The distribution of outcomes
for the entire group of pregnancies was (Table III): birth (39%), ongoing
pregnancy (14%), miscarriage (34%) and ectopic pregnancy (13%).
Pregnancies among youngerwomenweremore likely to result in birth
than amongolderwomen.Thiswas related to ahigher rateofmiscarriage
amongolderwomen.Womenwith tubal clip or ring sterilizations had the
highestproportionof births (50%), the lowest proportionofmiscarriages
(29%) and the lowest proportion of ectopic pregnancies (8%). Those
with coagulation sterilizations had the lowest proportion of births
(32%) and the highest proportion of miscarriages (38%) and ectopic
pregnancies (17%).
Birth rates
In total, 2314 (35%) patients had at least one live birth during follow-up,
and 598 who had not previously given birth had pregnancies ongoing
when follow-up ended. The rangewas 1–8 live births. Table IV provides
the raw proportions of women who ever gave birth during follow-up.
Since not all women were followed for the same length of time and
some pregnancies were ongoing at end of follow-up, these proportions
..............................
........................................................................................
Table I Patient characteristics according to ever
reporting a pregnancy during 14 years of follow-up.
Characteristic Total
n
Ever pregnant
after tubotubal
anastomosis
P-Value*
Yes, n (%) No, n (%)
Age at surgery (years) ,0.001
,30 899 737 (82%) 162 (18%)
30–34 2451 1907 (78%) 544 (22%)
35–39 2378 1625 (68%) 753 (32%)
≥40 964 364 (38%) 600 (62%)
Sterilization method ,0.001
Ring/clip 1661 1267 (76%) 394 (24%)
Ligation/resection 2688 1838 (68%) 850 (32%)
Coagulation 1762 1181 (67%) 581 (33%)
Other/NS† 581 347 (60%) 234 (40%)
Total 6692 4633 (69%) 2059 (31%)
†Includes various combinations ofmethods (25%) and unknownor not specified (NS).
*Log-rank P-value comparing time until first pregnancy across characteristic groups.
Figure 1 Kaplan–Meier estimates of cumulative pregnancy probabil-
ities over 3 years by (A) age at surgery group and (B) sterilization
method. NS, not specified.
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can be viewed as lower bounds on the actual live birth proportions. The
combined age and method-specific proportions vary substantially, from
63% for women under 30 years with tubal ring/clip sterilizations to 8%
forwomen aged 40 years orolderwhohad coagulation procedures. Esti-
mated cumulative incidences over 3 years, by age at reversal surgery and
by sterilization method, are shown in Fig. 2.
Discussion
The desire for pregnancy after tubal sterilization has public health impli-
cations. More than 10 million women in the USA and 180 million
women worldwide have had a sterilization procedure (Engender-
Health, 2002; Jones et al., 2012). Among ever-married women in the
USA aged 15–44 years in 1995, 26% reported having a tubal ligation
(Mosher et al., 2004); nearly 25% of women with an unreversed tubal
ligation said they and/or their partner wanted the sterilization reversed
(Chandra, 1998). In the US Collaborative Review of Sterilization, the
percentage of women expressing regret after a tubal ligation was 20%
for women aged 30 years or younger and 6% for women older than
30 years at the time sterilization. For women who were under 25
years of age at the time of sterilization, the regret rate was 40% (Hillis
et al., 1999).
Since microsurgical principles have been applied to tubal anastomosis
surgery, studies consistently have reported success, whether performed
by laparotomy or by laparoscopy with or without a surgical robot. Defi-
nitions of success have varied. The definitions include: tubal patency,
..................................................
.............................................................................................................................................................................................
Table II Pregnancy incidence by age and sterilization method.
Sterilization method Age (years) Number of women Became pregnant, n (%) Cumulative incidence of pregnancy
6-Month (%) 12-Month (%)
Ring/clip ,30 267 233 (88%) 60 77
30–34 619 513 (83%) 55 73
35–39 559 419 (75%) 49 66
≥40 216 99 (46%) 29 44
Ligation/resection ,30 359 289 (81%) 45 63
30–34 1017 777 (76%) 45 61
35–39 952 643 (68%) 39 55
≥40 360 129 (36%) 18 33
Coagulation ,30 216 170 (79%) 43 62
30–34 648 488 (75%) 43 61
35–39 654 435 (67%) 38 57
≥40 244 88 (36%) 15 26
Other/NS ,30 57 42 (74%) 51 61
30–34 167 129 (77%) 43 66
35–39 213 128 (60%) 32 50
≥40 144 48 (33%) 18 29
.............................................................................................................................................................................................
Table III Distribution of pregnancy outcomes* by age and sterilization method.
Characteristic Birth, n (%) Ongoing, n (%) Miscarriage, n (%) Ectopic, n (%) Total reported pregnancies
Age at surgery (years)
,30 535 (43%) 177 (14%) 379 (31%) 143 (12%) 1234
30–34 1270 (41%) 432 (14%) 965 (31%) 422 (14%) 3089
35–39 890 (36%) 346 (14%) 895 (36%) 336 (14%) 2467
≥40 121 (25%) 77 (16%) 232 (48%) 55 (11%) 485
Sterilization method
Ring/clip 993 (50%) 260 (13%) 583 (29%) 155 (8%) 1191
Ligation/resection 1047 (36%) 442 (15%) 1009 (35%) 417 (14%) 2915
Coagulation 592 (32%) 248 (13%) 703 (38%) 313 (17%) 1856
Other/NS 184 (36%) 82 (16%) 176 (34%) 71 (14%) 513
Total 2816 (39%) 1032 (14%) 2471 (34%) 956 (13%) 7275
*Some women reported multiple pregnancies.
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pregnancy, uterine pregnancy, ongoing pregnancy, viable pregnancy,
term pregnancy, delivery and birth. Studies have varied also from
months to years in lengths of post-operative follow-up.
We found 116 studies of the effectiveness of tubal anastomosis for
sterilization reversal in a comprehensive search of the English language
literature. Almost all were retrospective clinical case series or cohort
studies. Many of them have been cited in literature reviews (Gomel,
1977; Siegler et al., 1985; Dubuisson and Chapron, 1998; Deffieux
et al., 2011). A complete reference list is available upon request to the
communicating author.
Thirty-nine percent of the 116 studies were based on fewer than
30 patients with follow-up data. Thirty-seven percent of studies had
30–99 patients; 12% had 100–199 patients; 8% had 200–299 patients
and 4% had 300 or more patients in the study population. The number
of bilateral tubotubal anastomosis patients with follow-up data in all clin-
ical studies ranged from 3 to 960; the median was 44.
The largest study by far, prior to our study, was not a clinical one.
Payment data from the Quebec provincial health insurance system
identified women who underwent sterilization reversal surgery from
1980 through 1999. No information was provided about methods of
sterilization or sterilization reversal. Among 4369 women who had a
reversal after sterilization, 61% became pregnant and 48% achieved
a delivery (Trussell et al., 2003). The study design identified only com-
pleted pregnancies in the study population, the effect of which is a
higher proportion of deliveries and delivery rate than the proportion
of births and crude birth rate in our study population. If births and
ongoing pregnancies were combined into a single category in our
study, the crude birth/ongoing pregnancy rate would be more
similar to the delivery rate in the Quebec study.
Because the outcomes were unknown in 14% of pregnancies (the
ongoing pregnancies), the birth rates shown in this report understate
theactual birth rates in the studypopulation.Toconcludeotherwise,one
would have to assume that all ongoing pregnancies resulted in miscar-
riage or were ectopic. This assumption is improbable since many
ongoing pregnancies had progressed beyond the first trimester at last
patient contact.
Limitations of our study include probable underreporting of pregnan-
cies based on patient-initiated reports; possible errors in the reporting of
pregnancies or early miscarriages that may have been based solely on
home pregnancy tests; and probable over-reporting of the diagnosis of
ectopic pregnancies. Medical records of reported ectopic pregnancies,
when made available, showed that many were pregnancies of
unknown location that aborted spontaneously or after treatment with
methotrexate. Some of these may have been uterine pregnancies mis-
classified as ectopic pregnancies. Nevertheless, if a patient reported a
pregnancy tobeectopic—even if thediagnosiswassuspectedbutuncon-
firmed—it was coded as such in the database. The factors (age and ster-
ilization method) we identified as being associated with subsequent
pregnancy should not be interpreted as being predictive, because in
order to claim something to be a predictor, the association would
need to be validated in an independent second prospectively studied
group of representative patients.
As part of the informed consent process, patients were advised of the
increased risk of ectopic pregnancy associated with tubal reparative
........................................................................................
Table IV Women with any live births during follow-up
by age and sterilization method.
Sterilization
method
Age
(years)
Number of
women
Any live
births, n (%)
Ring/clip ,30 267 167 (63%)
30–34 619 348 (56%)
35–39 559 264 (47%)
≥40 216 37 (17%)
Ligation/resection ,30 359 149 (41%)
30–34 1017 388 (38%)
35–39 952 278 (29%)
≥40 360 43 (12%)
Coagulation ,30 216 75 (35%)
30–34 648 230 (35%)
35–39 654 159 (24%)
≥40 244 19 (8%)
Other/NS ,30 57 30 (53%)
30–34 167 61 (37%)
35–39 213 50 (23%)
≥40 144 16 (11%)
Figure 2 Kaplan–Meier estimates of cumulative live birth probabil-
ities over 3 years by (A) age at surgery group and (B) sterilization
method. NS, not specified.
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surgery. Instructions were given for early pregnancy monitoring with
serial hCG assays and transvaginal ultrasound examination. These
instructions were given at the time of surgery and repeated each time
a positive pregnancy test was reported. The instructions included the
recommendation for pregnancy termination to reduce the possible
risk of tubal rupture if no intrauterine gestation sac was observed by
the time serum hCG reached 2500–3000 mIU/ml.
Our definition of tubotubal anastomosis included anastomosis of any
distal segment to the interstitial tubal segment rather than defining these
as tubocornual or tubouterine anastomosis, as in some previous studies.
Wealso includedpatients in the studypopulationwhohadadditional sur-
gical procedures performed at the time of tubotubal anastomosis. Add-
itional procedures included uterinemyomectomy, fimbrioplasty, ovarian
cystectomy and adhesiolysis. These inclusions are additional factors that
could result in differences in pregnancy statistics in our study from other
patient populations.
Our literature search identified only one RCTof bilateral tubotubal
anastomosis for female sterilization reversal (Rock et al., 1984). This
study found no significant differences in pregnancies or pregnancy
outcomes using either loupe or microscope. Cochrane database
reviews have found no RCTs comparing laparoscopic, open or
robotic surgical techniques to reverse the effects of tubal sterilization
procedures (George et al., 2013), or comparing the effectiveness of
tubal reversal surgery with IVF (Yossry et al., 2006). In the absence
of such RCTs, couples and their clinicians must rely on observational
data.
The number of patients in this prospective study is considerably larger
than the populations of all previous studies of bilateral tubotubal anasto-
mosis. The large population size permits more accurate analysis of
factors associated with pregnancy and pregnancy outcomes than has
been possible previously.
Conclusion
Bilateral tubotubal anastomosis is a successful outpatient procedure
for women wanting fertility restored subsequent to tubal sterilization.
Pregnancy and birth rates vary widely depending on age and prior steril-
ization method. These factors are known before sterilization reversal
surgery and they were associated with long-term results with a high
degree of accuracy when taken into account simultaneously. This study
report will help inform patients and clinicians about tubal anastomosis
as an effective alternative to IVF.
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